Aldosterone response to angiotensin II during hypoxemia

Area of Science:

• Endocrinology
• Exercise Physiology
• Cardiovascular Research

Background:

• Exercise typically elevates plasma renin activity (PRA) and plasma aldosterone concentrations (PAC).
• Hypoxemic conditions, such as high altitude or breathing hypoxic gas, alter this response, with PRA increasing but PAC remaining suppressed.
• This suggests a potential inhibitor released during hypoxemia that interferes with angiotensin II's effect on aldosterone.

Purpose of the Study:

• To investigate whether hypoxemia induces the release of a circulating inhibitor that suppresses angiotensin II-mediated aldosterone secretion.
• To test the hypothesis by comparing PAC responses to angiotensin II infusions under normoxic and hypoxemic conditions.

Main Methods:

• Eight healthy volunteers participated in a crossover study.
• Plasma aldosterone concentration (PAC) responses to graded angiotensin II infusions were measured during normoxemia (room air) and hypoxemia (90% hemoglobin saturation).
• Angiotensin II was infused at increasing doses (2, 4, 8, 12 ng x kg-1 x min-1) over 20-minute periods on separate days.

Main Results:

• The infusion of angiotensin II led to a dose-dependent increase in PAC in both normoxemic and hypoxemic conditions.
• Crucially, the PAC response to angiotensin II did not significantly differ between the hypoxemic and normoxemic states.
• This indicates that hypoxemia, under the tested conditions, did not inhibit the aldosterone response to exogenous angiotensin II.

Conclusions:

• The study concludes that the tested model of hypoxemia does not lead to the release of an inhibitor of angiotensin II-mediated aldosterone release.
• The suppression of PAC during hypoxemic exercise is not explained by an inhibitory factor blocking angiotensin II's action.
• Further research is needed to elucidate the precise mechanisms behind PAC suppression during hypoxemic exercise.